Palvella Therapeutics, Inc. PVLA
NASDAQ · United States · Health Technology
$135.12-2.81 (-2.04%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -1.52 | -1.17 | -29.6% | $0 | — | +10.0%$140.78→$154.91 |
| Q1 2026 | 2026-05-07 | -1.20 | -0.90 | -33.3% | — | — | -6.8%$130.17→$121.29 |
| Q4 2025 | 2026-03-31 | -1.08 | -0.91 | -18.7% | — | — | +8.8%$110.66→$120.38 |
| Q3 2025 | 2025-11-11 | -1.03 | -0.85 | -21.2% | — | — | +1.6%$80.29→$81.54 |
| Q4 2024 | 2025-03-31 | -5.37 | -0.60 | -795.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.